NCT01355107
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +21 more
- Locations
-
- University Medical Center Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
Clinical trial condition
Carcinoma
Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.
8,781 public trials
2,085 recruiting studies
Carcinoma trial results
NCT01426126
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
- Locations
-
- Asan Medical Center Seoul, South Korea
NCT00003887
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +123 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00197860
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +14 more
- Locations
-
- Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark
NCT00280852
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
- Locations
-
- Tom Baker Cancer Centre Calgary, Alberta, Canada
NCT00298545
- Conditions
- Adenocarcinoma, Carcinoma, Colorectal Adenoma, +4 more
- Locations
-
- Rockefeller University Hospital New York, United States
Completed
Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00425750
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
- Locations
-
- Jennie Stuart Medical Center Hopkinsville, Kentucky, United States
- Purchase Cancer Group - Paducah Paducah, Kentucky, United States
- Tennessee Plateau Oncology - Crossville Crossville, Tennessee, United States
- West Tennessee Cancer Center at Jackson-Madison County General Hospital Jackson, Tennessee, United States
NCT00158652
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +22 more
- Locations
-
- CHU de Tours Tours, France
- Institut Gustave Roussy Villejuif, France
NCT00927043
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Pfizer Investigational Site Pamplona, Navarre, Spain
NCT01246843
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- University Medical Centre Nijmegen Nijmegen, Gelderland, Netherlands